Stocks and Investing Stocks and Investing
Mon, August 27, 2012

Andrew Peters Downgraded (BMRN) to Hold and Held Target at $45 on, Aug 27th, 2012


Published on 2024-10-25 00:22:03 -
  Print publication without navigation


Andrew Peters of Deutsche Bank, Downgraded "BioMarin Pharmaceutical Inc." (BMRN) to Hold and Held Target at $45 on, Aug 27th, 2012.

Andrew has made no other calls on BMRN in the last 4 months.



There are 2 other peers that have a rating on BMRN. Out of the 2 peers that are also analyzing BMRN, 0 agree with Andrew's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Andrew


  • Gena Wang of "Barclays" Initiated at Buy and Held Target at $46 on, Friday, August 24th, 2012
  • Matthew Harrison of "Morgan Stanley" Maintained at Strong Buy with Increased Target to $52 on, Monday, July 23rd, 2012